Gal-12 helps to differentiate the tissue of APL cells, and inhibiting Gal-12 can promote granulocyte differentiation of APL cells, which might serve as a potential target for treating resistance in APL (Fig. 3) [175]. This evidence concerns the gene LGALS12 and acute promyelocytic leukemia.